We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ABEO market cap is 105.78M. The company's latest EPS is USD -2.1874 and P/E is -1.96.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 68k | 0 | 3.5M | 0 | 1.07M |
| Operating Income | -9.89M | -12.04M | -11.62M | -11.33M | -12.14M |
| Net Income | -1.13M | -9.11M | -16.65M | -11.84M | -16.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 10M | 3M | 1.41M | 4.57M |
| Operating Income | -77.09M | -81.42M | -89.84M | -47.77M | -47.14M |
| Net Income | -76.28M | -84.23M | -84.94M | -43.48M | -54.19M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 64.21M | 53.35M | 53.55M | 66.09M | 64M |
| Total Liabilities | 37.45M | 34.61M | 44.21M | 44.05M | 49.18M |
| Total Equity | 26.76M | 18.74M | 9.35M | 22.04M | 14.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 223.38M | 151.2M | 79.59M | 64.21M | 64M |
| Total Liabilities | 44.95M | 48.65M | 28.21M | 37.45M | 49.18M |
| Total Equity | 178.43M | 102.55M | 51.38M | 26.76M | 14.83M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -43.48M | -11.74M | -22.03M | -27.77M | -37.01M |
| Investing | -23.96M | 2.21M | 7.42M | -11.32M | 208k |
| Financing | 43.17M | -4k | 6.61M | 29.59M | 37.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -62.82M | -35.02M | -65.67M | -43.48M | -37.01M |
| Investing | 59.98M | -83.71M | 66.06M | -23.96M | 208k |
| Financing | 113.9M | 1.94M | 24.86M | 43.17M | 37.06M |
| Market Cap | 105.78M |
| Price to Earnings Ratio | -1.96 |
| Price to Sales Ratio | 23.22 |
| Price to Cash Ratio | 7.33 |
| Price to Book Ratio | 7.15 |
| Dividend Yield | - |
| Shares Outstanding | 24.77M |
| Average Volume (1 week) | 499.59k |
| Average Volume (1 Month) | 592.36k |
| 52 Week Change | 6.48% |
| 52 Week High | 9.01 |
| 52 Week Low | 2.83 |
| Spread (Intraday) | 0.15 (3.39%) |
| Company Name | Abeona Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.abeonatherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
